News Search Results
May 08, 2024, 17:15 ET Synthetic Biology Market size to record USD 28.25 billion growth from 2023-2027, Evolving regulatory framework around synthetic biology is one of the key market trends, Technavio
Key Trends Fueling Growth Evolving regulatory framework around synthetic biology: Companies are increasingly utilizing synthetic biology, prompting governments worldwide to revamp regulations for safety. Biosafety and biosecurity are pivotal,
More news about: Technavio
May 07, 2024, 22:00 ET NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investments from Celadon Partners and ClavystBio
biomedical, agrifood, and industrial biotechnology sectors, working in areas such as precision medicine, nucleic acids, AI-enabled drug discovery, and synthetic biology. With the largest co-working biotech laboratory and office footprint in Singapore, coupled with extensive networks
More news about: NSG BioLabs
May 07, 2024, 16:58 ET Amyris Announces Kathy Fortmann as New CEO
Calif., May 7, 2024 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company that creates sustainable, market-ready ingredients utilizing proprietary advanced precision fermentation technology and world-class platforms,
More news about: Amyris, Inc.
May 07, 2024, 10:00 ET Think Bioscience extends Seed Round to accelerate pocket-finding platform
May 7, 2024 /PRNewswire/ -- Think Bioscience ("Think"), a Boulder-based synthetic biology company focused on developing small-molecule therapeutics that target "undruggable" proteins, has announced a $6M Seed Expansion. Existing investors
More news about: Think Bioscience
May 07, 2024, 08:00 ET Molecular Assemblies Launches Partner Program for Onsite Synthesis of Long, Pure, Accurate DNA
length, limited to the first 20 customers. "It's exciting to hear from our customers that we are delivering on their needs for a variety of synthetic biology applications including CRISPR, molecular cloning, and gene assembly, as well as next generation sequencing," said Phil
More news about: Molecular Assemblies, Inc.
May 07, 2024, 07:01 ET GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel Sweetener
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
May 06, 2024, 07:01 ET Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
May 06, 2024, 06:36 ET The Liquid Crystal Revolution: Leading the Global Market to Greater Heights with a (CAGR) of 6.1% between 2023 and 2028
therapeutic applications. • Rising government investments for synthetic biology and genome projects. • Growing focus on personalized
More news about: BCC Research LLC
May 01, 2024, 21:30 ET Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
redefining cancer cell therapy. *1 ACCEL™ technology and convertibleCAR®: ACCEL™ technology is based on a synthetic biology approach that utilizes the binding of an engineered protein ligand to an orthogonal engineered receptor which forms the extracellular domain of
More news about: ASTELLAS PHARMA INC.
May 01, 2024, 09:00 ET Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
cell therapy. *1 ACCELTM technology and convertibleCAR®: ACCELTM technology is based on a synthetic biology approach that utilizes the binding of an engineered protein ligand to an orthogonal engineered receptor which forms the extracellular domain of
More news about: Poseida Therapeutics, Inc.
May 01, 2024, 08:00 ET Mission BioCapital Announces 2024 Platinum Program Contest with Partners Eli Lilly and Company, Ono Venture Investment, and Alloy Therapeutics
(Tipping Point Biosciences, San Francisco, CA); and development of next-generation therapeutics by combining synthetic biology and machine learning to control cellular stress responses (Integrated Biosciences, San Carlos, CA). The six winners
More news about: Mission BioCapital
May 01, 2024, 07:00 ET Ayana Bio Awarded National Institutes of Health Grant to Harness Neuroprotective Benefits from Plant Cell-Cultivated Saffron
highest neuroprotective benefits, specifically for Huntington's disease. The company will use its high-throughput synthetic biology capabilities of sequencing, multi-omics technology, and analytical chemistry to explore and select the best plant cell lines. The research will
More news about: Ayana Bio
May 01, 2024, 05:32 ET From Base Pairs to Billions: Oligonucleotides' Remarkable Market Trajectory Driven by Thriving 11.0% CAGR Growth Globally
body, and it's becoming more common as we learn more about how genes work and how diseases develop.Rising government investments for synthetic biology and genome projects.: The government is putting more money into projects that involve making artificial genetic material and studying entire
More news about: BCC Research LLC
Apr 29, 2024, 16:01 ET Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Apr 26, 2024, 10:30 ET Oligonucleotide Synthesis Market Worth $19.7 billion | MarketsandMarkets™
therapeutic and diagnostic applicationsTechnological advancementsGrowing government investments in life science research and synthetic biologyGrowing focus on precision/personalized medicineRestraints: Complexities associated with therapeutic
More news about: MarketsandMarkets
Apr 24, 2024, 17:40 ET Genomics Market size in US to record USD 5.28 billion growth from 2023-2027, Growing adoption of single cell-based genomics analysis is one of the key market trends, Technavio
players such as Illumina, Thermo Fisher Scientific, and Qiagen leading the way. The use of genomics in gene therapy, gene editing, and synthetic biology is also expected to provide new opportunities for market growth. The market is segmented by application, technology, and end user. The major applications
More news about: Technavio
Apr 17, 2024, 17:15 ET Marine Biotechnology Market size to record USD 4.37 billion growth from 2023-2027, Increasing concern about climate change is one of the key market trends, Technavio
antitumoral, and antiviral agents. Functional food ingredients, such as polyunsaturated fatty acids, are discovered through marine research, while synthetic biology and genetic engineering advance drug discovery. Marine Viruses and Corals and Sponges offer further opportunities for biomedical applications.
More news about: Technavio
Apr 16, 2024, 07:02 ET Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Apr 11, 2024, 14:16 ET New England Biolabs® launches Monarch® Mag Viral DNA/RNA Extraction Kit to enable highly sensitive viral detection
NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key
More news about: New England Biolabs, Inc.
Apr 11, 2024, 07:01 ET Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"
Ferment conference. The conference brings together stakeholders from across the synthetic biology community, including R&D leaders,
More news about: Ginkgo Bioworks
Apr 11, 2024, 07:01 ET Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Apr 10, 2024, 11:00 ET Toyota Ventures Raises Another $300 Million to Expand Early-Stage Investments in Frontier Technology and Climate Solutions
on our initial Frontier and Climate Funds. With seismic breakthroughs in generative AI, e-fuels, space commercialization, carbon capture, and synthetic biology, it's a crucial time to be investing for Toyota." TVFF II will focus on startups at the cutting edge of deep technology in
More news about: Toyota Ventures
Apr 10, 2024, 07:02 ET Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain
initial work with Ginkgo focused on exploring strategies for a more effective future production process. We look forward to leveraging Ginkgo's synthetic biology platform across our R&D pipeline, from discovery through new ways of manufacturing, in this broader strategic partnership. Moreover, we are
More news about: Ginkgo Bioworks
Apr 10, 2024, 07:01 ET Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Apr 04, 2024, 07:01 ET Ginkgo Bioworks to Host 5th Annual Ferment Conference
Thursday, April 11, 2024 in Boston, MA. The conference brings together stakeholders from across the synthetic biology ecosystem and the Ginkgo community, from shareholders and customers to suppliers, academics, and many more.
More news about: Ginkgo Bioworks